• Kahini Roy
• Dr. Suresh Janadri
• Nandana R Das
• Krishnakhi Das
• Dr. Manjunatha P.M.

A metabolic condition known as diabetes is characterized by elevated blood sugar levels, brought on by deviations in insulin synthesis, and action. The kidney condition known as diabetic nephropathy (DN) often appears among individuals with diabetes for 10 to 20 years. Diabetes nephropathy may be treatable with stem cell therapy. It is critical to discover a novel therapeutic approach to treat DN because existing treatments, such as hyperglycemia and blood pressure management, can only partially halt the development of the disease. Adipose-derived stem cell (ADSC) transplantation has been established to enhance the capacity for cell repair and restoration, and adult mesenchymal stem cells (MS) have been attributed to the reduction of DN. There is evidence that oxidative stress is an underlying process in the progression of diabetic problems.

Diabetes Mellitus, Diabetes Nephropathy, hyperglycemia, Stem cells, CVD

"Stem Cell Therapy for Diabetes Complications: Current Evidence and Potential Role in Diabetic Nephropathy", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 11, page no.b559-b569, November-2023, Available :http://www.jetir.org/papers/JETIR2311166.pdf

"Stem Cell Therapy for Diabetes Complications: Current Evidence and Potential Role in Diabetic Nephropathy", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 11, page no. ppb559-b569, November-2023, Available at : http://www.jetir.org/papers/JETIR2311166.pdf